ARCHIVES

Shingleton To Retire As Director Of Duke Comprehensive Center

This article is from The Cancer Letter archive.

Vol. 07 No. 28 | July 10, 1981

Download PDF Visit The Full Archive

Related Articles

In Brief: Broder Resigns From IVX; Bishop To Receive Public Service Award; Johnston Rejoins NIAID

August 7, 1998

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

‘We Cannot Tolerate One Third Reduction In Centers. Prevention, Clinical Trials Programs’

September 20, 1991

DRCCA To Get Name Change, Three Major Program Areas

August 27, 1982

Senate Committee Blocks Effort To Overturn Organ Systems Changes

December 10, 1982